- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01564771
Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (B1851065)
30. november 2018 oppdatert av: Pfizer
Serotype distribution and estimation of antimicrobial resistance in S. pneumoniae isolates and anticipated PCV7 and PCV13 coverage is difficult in Greece, because invasive isolates collected each year are limited and depict a certain proportion of patients who have easy access to tertiary care or have underlying medical reasons which necessitate inpatient care.
It is also probable that the real burden of pneumococcal disease is not well estimated especially among adults.
New additions in the laboratory setting such as the pneumococcal urine antigen assay (Binax NOW®) and the Urinary Antigen Diagnostic Assay (Luminex) for the detection of 13 serotype specific polysaccharides in human urine developed by Pfizer might be helpful in identifying more pneumococcal infections compared to the previous years.
This NIS is based on the unmet scientific need to describe the serotype distribution and the resistance profile of isolates from X-Ray confirmed CAP in the present circumstances.
Studieoversikt
Detaljert beskrivelse
For each surveillance period lasting for 12 months all adults presenting in the selected clinics with symptoms and signs suggestive of pneumonia (candidate cases) will be asked to participate in the study
Studietype
Observasjonsmessig
Registrering (Faktiske)
293
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Alexandroupoli, Hellas, 68100
- General University Hospital of Alexandroupoli
-
Athens, Hellas, 11527
- General Chest Diseases Hospital "Sotiria"/ 7th Department of Pulmonary Medicine
-
Athens, Hellas, 11527
- General Hospital of Athens "Sotiria"/ 12Th Pneumonology Clinic
-
Athens, Hellas, 11527
- General Hospital of Athens "Sotiria"/ 1St Pneumonology Clinic
-
Athens, Hellas, 11527
- General Hospital of Athens "Sotiria"/ 2Nd Pneumonology Clinic
-
Athens, Hellas, 11527
- General Hospital of Athens "Sotiria"/ 5Th Pneumonology Clinic
-
Athens, Hellas, 11527
- General Hospital of Athens "Sotiria"/ 6Th Pneumonology Clinic
-
Athens, Hellas, 11527
- General Hospital of Athens "Sotiria"/ 8Th Pneumonology Clinic
-
Athens, Hellas, 15123
- Diagnostic Therapeutic Center of Athens Ygeia
-
Athens, Hellas, 15126
- General Hospital Athens "Sismanoglio"/ 1St Pneumonology Clinic
-
Athens, Hellas, 15126
- General Hospital of Athens "Sismanoglio" / 3Rd Pneumonology Department
-
Athens, Hellas, 15126
- General Hospital of Athens "Sismanoglio"/ 2Nd Pneumonology Clinic
-
Athens, Hellas, 15127
- General Hospital Mellision "Amalia Fleming"/ Pneumonology Clinic
-
Athens, Hellas, 15127
- General Hospital Mellision "Amalia Fleming"/2nd Internal Medicine Department
-
Athens, Hellas, 15227
- Sotiria Hospital, Intensive Care Unit
-
Athnens, Hellas
- General University Hospital "Attikgeneral University Hospital "Attikon"/ 4Th University Internal Med
-
Kavala, Hellas, 65201
- General Hospital of Kavala/ A Pneumonological Clinic
-
Kavala, Hellas, 65201
- General Hospital of Kavala/ b Pneumonological & Tubeculosis Department
-
Larissa, Hellas, 41 110
- University General Hospial of Larissa, Pneumonology Department
-
-
Attiki
-
Athens, Attiki, Hellas
- General Hospital of Athens "Evangelismos" / Pneumonology Department
-
-
Evros
-
Alexandroupoli, Evros, Hellas, 68100
- University Hospital of Alexandroupolis
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Prøvetakingsmetode
Ikke-sannsynlighetsprøve
Studiepopulasjon
Adults ≥18 years of age with chest X-ray confirmed CAP
Beskrivelse
Inclusion Criteria:
- Patients who agreed to participate in the study and agreed to sign an ICD.
- Patients had to be ≥18 years of age (adults)
- Patients had to present or had been referred to a participating healthcare facility with suspected pneumonia based on the physician's assessment (including but not limited to specific signs and symptoms described in Section 9.3 of the protocol)
- Patients must have had a posteroanterior or anteroposterior chest X-ray showing an infiltrate (if previous films were not available) or a new infiltrate (if recent film was available)
- Patients had to be tested positive for the Binax NOW® assay (required post Protocol Amendment 2)
Exclusion Criteria:
- Patients who did not sign an ICD.
- Any patient who developed signs and symptoms of pneumonia after being hospitalized for ≥48 hours
- Any patient who was transferred to a study healthcare facility after already being hospitalized for ≥48 hours at another healthcare facility
- Patients who did not have a chest X-ray performed
- Patients who did not have the Binax NOW® assay performed
- Patients with negative results for the Binax NOW® assay (required post Protocol Amendment 2)
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: Bare etui
- Tidsperspektiver: Potensielle
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Group one
Adults ≥18 years of age with chest X-ray confirmed CAP
|
This Is A Non Interventional Study
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The frequency of serotypes 4,6B,9V,14,18C,19F,23F,1,3,5,6A,7F and 19A from chest X-ray confirmed pCAP patients (post amendment2 with positive Binax NOW® only) who presented in the emergency departments of 15 hospitals in Greece during 1
Tidsramme: One year
|
One year
|
|
calendar year.
Tidsramme: One year
|
One year
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Susceptibility, resistance or partial resistance Streptococcus pneumoniae clinical isolates obtained from study adult CAP patients.
Tidsramme: One year
|
One year
|
|
The frequency of the 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 6A, 7F, 19A serotypes (based on Luminex assay) of study patients immunized and not immunized with PPV.
Tidsramme: One year
|
One year
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. januar 2011
Primær fullføring (Faktiske)
1. april 2013
Studiet fullført (Faktiske)
1. april 2013
Datoer for studieregistrering
Først innsendt
26. mars 2012
Først innsendt som oppfylte QC-kriteriene
27. mars 2012
Først lagt ut (Anslag)
28. mars 2012
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
3. desember 2018
Siste oppdatering sendt inn som oppfylte QC-kriteriene
30. november 2018
Sist bekreftet
1. november 2018
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- B1851065
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .